In memoriam - IRIC pays tribute to Dr. André Robidoux
Published on August 13, 2020
It was with great sadness that IRIC learned of the death of André Robidoux, who passed away on July 25, surrounded by his family.
Renowned surgical oncologist, his body of work included being part of the National Surgical Adjuvant Breast and Bowel Project to promote clinical tests aimed at validating new therapies. Devoted to his patients, he also wanted to convey his knowledge to them. His book, Les raisons d’espérer : ce que la recherche nous apprend sur le cancer du sein (Les Presses de l’Université de Montréal, 2013), enlightens the general public on the major advances in treating breast cancer.
A visionary, he drew on the model of the MD Anderson Cancer Center of the University of Texas to promote synergy between care and research. He was the creator and Director of the CHUM Breast Cancer Research Group and the Founding President of the Scientific Executive Committee for the McPeak-Sirois Group for Clinical Research in Breast Cancer. Serving as the UdeM’s Scotiabank Chairholder in the diagnosis and treatment of breast cancer for 18 years, André Robidoux was also an Associate Investigator at IRIC where he actively promoted the application of fundamental research results to therapeutic development.
IRIC extends its condolences to his family and will honour his memory and his legacy.